US Stock MarketDetailed Quotes

CMRX Chimerix

Watchlist
  • 1.000
  • +0.047+4.94%
Close May 6 16:00 ET
89.63MMarket Cap-1063P/E (TTM)

About Chimerix Company

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.

Company Profile

SymbolCMRX
Company NameChimerix
Listing DateApr 11, 2013
Issue Price14.00
Founded2000
CEOMr. Michael T. Andriole
MarketNASDAQ
Employees72
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2505 Meridian Parkway,Suite 100
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27713
Phone1-919-806-1074

Company Executives

  • Name
  • Position
  • Salary
  • Michael T. Andriole
  • Director, Chief Executive Officer and President
  • 1.31M
  • Michelle LaSpaluto
  • Chief Financial Officer
  • --
  • Dr. Allen S. Melemed
  • Chief Medical Officer
  • 931.79K
  • Thomas J. Riga
  • Chief Operating Officer and Chief Commercial Officer
  • --
  • David Jakeman
  • Vice President, Finance and Accounting and Principal Accounting Officer
  • --
  • Dr. Michael A. Alrutz,PhD
  • Senior Vice President, General Counsel and Corporate Secretary
  • 793.85K
  • Michael Sherman
  • Chairman of the Board
  • 1.52M
  • Marc D. Kozin
  • Director
  • --
  • Patrick C. Machado, J.D.
  • Independent Director
  • 124.52K
  • Dr. Pratik S. Multani, M.D.
  • Independent Director
  • 104.52K
  • Fred A. Middleton
  • Independent Director
  • 119.52K
  • Dr. Robert J. Meyer, M.D.
  • Independent Director
  • 117.02K
  • Victoria Vakiener
  • Independent Director
  • 107.02K
  • Martha J. Dei
  • Lead Independent Director
  • 144.52K
  • Lisa Lynn Decker, PhD
  • Independent Director
  • 67.78K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg